Free Access
| Issue |
Radioprotection
Volume 39, Number 4, October-December 2004
|
|
|---|---|---|
| Page(s) | 481 - 492 | |
| DOI | https://doi.org/10.1051/radiopro:2004012 | |
| Published online | 17 June 2005 | |
- Arrêté (2004) arrêté du 21 janvier 2004 relatif à l’information des personnes exposées aux rayonnements ionisants lors d’un acte de médecine nucléaire. [Google Scholar]
- Barrington S.F., Kettle A.G., O’Doherty M.J., Wells C.P., Somer E.J.R., Coakley A.J. (2002) Radiation dose rates from patients receiving iodine-131 therapy for carcinoma of the thyroid, Eur. J. Nucl. Med. 23, 123-130. [Google Scholar]
- British Institute of Radiology (1999) Working party of the Radiation Protection Committee Patients leaving hospital after administration of radioactive substances, Br. J. Radiol. 72, 121-125. [Google Scholar]
- Bockisch A., Jamitzky T., Derwanz R., Biersack H.J. (1993) Optimized dose planning of radioiodine therapy of benign thyroidal diseases, J. Nucl. Med. 34, 1632-1638. [Google Scholar]
- Commission de la communauté européenne (1999) Radioprotection 97. Radioprotection à la suite d’une thérapie à l’iode 131 (expositions dues aux patients externes ou aux patients hospitalisés sortants). Direction générale Environnement, sécurité nucléaire et protection civile. [Google Scholar]
- Commission of the European Communities (1996) Basic safety standards for the health protection of the general public and the workers against the dangers of ionising radiation. Council directive 96/29 Euratom, Brussels. [Google Scholar]
- Commission of the European Communities (1997) Health protection of individuals against the dangers of ionising radiation in relation to medical exposure. Council directive 97/43, Brussels. [Google Scholar]
- Culver C.M., Dworkin H.J. (1992) Radiation safety considerations for post-iodine-131 thyroid cancer therapy, J. Nucl. Med. 33, 1402-1405. [Google Scholar]
- Décret (2002) décret n° 2002-460 du 4 avril 2002 relatif à la protection générale des personnes contre les dangers des rayonnements ionisants. [Google Scholar]
- Décret (2003) décret n° 2003-296 du 31 mars 2003 relatif à la protection des travailleurs contre les dangers des rayonnements ionisants. [Google Scholar]
- Gates V.L., Carey J.E., Siegel J.A., Kaminski M.S., Wahl R.L. (1998) Nonmyeloablative iodine-131 anti-b1 radioimmunotherapy as outpatients therapy, J. Nucl. Med. 39, 1230-1236. [PubMed] [Google Scholar]
- Gertrud E.B., Michanek A.M.K., Holmberg E.V.C., Fink M. (1996) Iodine-131 treatment of hyperthyroidism: significance of effective half-life measurements, J. Nucl. Med. 37, 228-232. [Google Scholar]
- Guedj E., de la Forte C., Poinsot L., Bourrely M. (2003) Exposition du public et de l’entourage après traitement d’un patient par 3,7 GBq d’131I pour un cancer thyroïdien différencié, Médecine Nucléaire – Imagerie Fonctionnelle et Métabolique 27, 649-654. [Google Scholar]
- ICRP Publication 53 (1988) Radiation dose to patients from radiopharmaceuticals, Ann. ICRP 18, 261. [Google Scholar]
- ICRP Publication 60 (1991) 1990 Recommendations of the International Commission on Radiological Protection, Ann. ICRP 21 (1-3). [Google Scholar]
- ICRP Publication 73 (1996) Radiological protection and safety in medicine, Ann. ICRP 26 (2). [Google Scholar]
- Monsieurs M., Thierens H., Dierckx R.A., Casier K., De Baere E., De Ridder L., De Saedeleer C., De Winter H., Lippens M., Imschoot S., Wulfrank D., Simons M. (1998) Real-life radiation burden to relatives of patients treated with iodine-131 : a study in eight centres in flanders (belgium), Eur. J. Nucl. Med. 25, 1368-1376. [Google Scholar]
- Siegel J.A., Marcus C.S., Sparks R.B. (2002a) Calculating the absorbed dose from radioactive patients: The line-source versus point-source model, J. Nucl. Med. 43, 1241-1244. [PubMed] [Google Scholar]
- Siegel J.A., Kroll S., Regan D., Kaminski M.S., Wahl R.L. (2002b) A practical methodology for patient release after tositumomab and 131I-tositumomab therapy, J. Nucl. Med. 43, 354-363. [PubMed] [Google Scholar]
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.